thymic Stromal Lymphopoietin
Aiolos Bio debuts with $250M and ex-Gyroscope CEO to tackle severe asthma
Anika Sharma
A striking trend throughout 2023 has been the gravitational pull of significant funding toward promising biotech endeavors. This theme is ...
